Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Deal represents AstraZeneca's third major collaboration in 12 months
Sales growth rate of 23% in 2005 set to increase even further
But cost could could prove a major obstacle
Inconclusive investigation results deter investors
Drug provides relief from chronic pain in opioid-resistant patients
Superior potency should make it a new first-line choice
Weight-loss drug also helps combat diabetes and heart disease
Ranbaxy generic blocked until 2011
But British Thoracic Society says more measures must be put in place
J&J's protease inhibitor offers new option for patients
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches